Nature Communications (Oct 2022)
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
Abstract
Plasma B cells (PC) are a potential source for protein replacement as they could be engineered to secrete protein other than antibody. Here the authors engineer B cells to express exogenous proteins and demonstrate that these cells can persist long term in adoptive transfer experiments in mice.